These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30226545)

  • 1. Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network.
    Wang X; Han L; Zhou L; Wang L; Zhang LM
    Oncol Rep; 2018 Nov; 40(5):2659-2673. PubMed ID: 30226545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A competing endogenous RNA network identifies novel mRNA, miRNA and lncRNA markers for the prognosis of diabetic pancreatic cancer.
    Yao K; Wang Q; Jia J; Zhao H
    Tumour Biol; 2017 Jun; 39(6):1010428317707882. PubMed ID: 28639886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network.
    Tang Z; Wei G; Zhang L; Xu Z
    Mol Med Rep; 2019 Jun; 19(6):4806-4818. PubMed ID: 31059106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a SVM classifier to predict recurrence of ovarian cancer.
    Zhou J; Li L; Wang L; Li X; Xing H; Cheng L
    Mol Med Rep; 2018 Oct; 18(4):3589-3598. PubMed ID: 30106117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
    Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
    Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated analysis of a competing endogenous RNA network reveals an 11-lncRNA prognostic signature in ovarian cancer.
    Zhang Y; Zhou H; Zhang M; Xing L; Yang C; Xia B; Lou G
    Aging (Albany NY); 2020 Nov; 12(24):25153-25171. PubMed ID: 33223503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competing endogenous RNA network analysis for screening inflammation‑related long non‑coding RNAs for acute ischemic stroke.
    Zhang L; Liu B; Han J; Wang T; Han L
    Mol Med Rep; 2020 Oct; 22(4):3081-3094. PubMed ID: 32945445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SSTR5‑AS1 functions as a ceRNA to regulate CA2 by sponging miR‑15b‑5p for the development and prognosis of HBV‑related hepatocellular carcinoma.
    Xu J; Zhang J; Shan F; Wen J; Wang Y
    Mol Med Rep; 2019 Dec; 20(6):5021-5031. PubMed ID: 31638225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Biomarkers in Wilms' Tumor.
    Zheng H; Li BH; Liu C; Jia L; Liu FT
    Biomed Res Int; 2020; 2020():4951692. PubMed ID: 32149111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of RNA Expression Profiles in Thyroid Cancer to Construct a Competing Endogenous RNA (ceRNA) Network of mRNAs, Long Noncoding RNAs (lncRNAs), and microRNAs (miRNAs).
    Xu Y; Chen J; Yang Z; Xu L
    Med Sci Monit; 2019 Feb; 25():1140-1154. PubMed ID: 30745559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of implantation failure related lncRNA-mRNA network and identification of lncRNA biomarkers for predicting endometrial receptivity.
    Feng C; Shen JM; Lv PP; Jin M; Wang LQ; Rao JP; Feng L
    Int J Biol Sci; 2018; 14(10):1361-1377. PubMed ID: 30123082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of Competing Endogenous RNA Networks Incorporating Transcription Factors to Reveal Differences in Granulosa Cells from Patients with Endometriosis.
    Wu R; Li J; Li J; Zhang N; Zhou W; Ren L; Chen Q; Li Y
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):453-462. PubMed ID: 34280006
    [No Abstract]   [Full Text] [Related]  

  • 13. TCGA dataset‑based construction and integrated analysis of aberrantly expressed long non‑coding RNA mediated competing endogenous RNA network in gastric cancer.
    He W; Zhang D; Li X; Wu J; Yang X; Wang Q; Lu W; Jiang J; Wu C
    Oncol Rep; 2018 Dec; 40(6):3511-3522. PubMed ID: 30272352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
    Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
    Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Building a Competing Endogenous RNA Network to Find Potential Long Non-Coding RNA Biomarkers for Pheochromocytoma.
    Liang YC; Wu YP; Chen DN; Chen SH; Li XD; Sun XL; Wei Y; Ning X; Xue XY
    Cell Physiol Biochem; 2018; 51(6):2916-2924. PubMed ID: 30562748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analysis of long non-coding RNA‑associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma.
    Sui J; Li YH; Zhang YQ; Li CY; Shen X; Yao WZ; Peng H; Hong WW; Yin LH; Pu YP; Liang GY
    Int J Oncol; 2016 Nov; 49(5):2023-2036. PubMed ID: 27826625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of the tumor-specific ceRNA network in epithelial ovarian cancer.
    Li G; Han L; Ren F; Zhang R; Qin G
    J Cell Physiol; 2019 Dec; 234(12):22071-22081. PubMed ID: 31152442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of competing endogenous RNA (ceRNA) networks in subacute stage of spinal cord injury.
    Wang N; He L; Yang Y; Li S; Chen Y; Tian Z; Ji Y; Wang Y; Pang M; Wang Y; Liu B; Rong L
    Gene; 2020 Feb; 726():144171. PubMed ID: 31669638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and analysis of dysregulated lncRNA-associated ceRNA network in colorectal cancer.
    Zhu Y; Bian Y; Zhang Q; Hu J; Li L; Yang M; Qian H; Yu L; Liu B; Qian X
    J Cell Biochem; 2019 Jun; 120(6):9250-9263. PubMed ID: 30525245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 19‑miRNA Support Vector Machine classifier and a 6‑miRNA risk score system designed for ovarian cancer patients.
    Dong J; Xu M
    Oncol Rep; 2019 Jun; 41(6):3233-3243. PubMed ID: 31002358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.